$3,500.00
GBI Research’s report: “Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for .....
Published: May-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research: ‘Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and.....
Published: Apr-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines market to 2019 – Pipeline Indicates Safer Treatments and Extended Patient Surviv.....
Published: Mar-2013
|
$3,500.00
Leading business intelligence provider GBI Research has released its latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 – Nexavar, the Only Approved Targeted Therapy for Advan.....
Published: Dec-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Leukemia Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share” which pro.....
Published: Nov-2012
|
$3,500.00
Leading business intelligence provider GBI Research has released its latest research report, entitled “Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing .....
Published: Jul-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Cla.....
Published: Jul-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Cytotoxic Therapies Market to 2017 – Launch of Next Generation Camptothecin Analogues Will Help Offset Reve.....
Published: Apr-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Orphan Diseases Therapeutics in Oncology to 2018- Strongly Diversified Developmental Pipelines Indicate Long.....
Published: Apr-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Therapeutics Market to 2017 – High Unmet Need in Management and Treatment of Metastatic Cancers to.....
Published: Dec-2011
|
$3,500.00
GBI Research’s new report, “Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline Due to Generic Erosion and Entry of Biosimilars”, provides in-depth analysis of unmet needs, .....
Published: Apr-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market”. The report .....
Published: Feb-2011
|
$3,500.00
GBI Research's pharmaceutical research, “Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market”, which prov.....
Published: Jan-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Market in India to 2017 – Limited Patient Affordability for High Priced Biologics Lowers Market Po.....
Published: Dec-2010
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline a.....
Published: Dec-2009
|